JP2002520286A5 - - Google Patents

Download PDF

Info

Publication number
JP2002520286A5
JP2002520286A5 JP2000558822A JP2000558822A JP2002520286A5 JP 2002520286 A5 JP2002520286 A5 JP 2002520286A5 JP 2000558822 A JP2000558822 A JP 2000558822A JP 2000558822 A JP2000558822 A JP 2000558822A JP 2002520286 A5 JP2002520286 A5 JP 2002520286A5
Authority
JP
Japan
Prior art keywords
composition
formula
caffeine
compound
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000558822A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002520286A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/013670 external-priority patent/WO2000002562A1/en
Publication of JP2002520286A publication Critical patent/JP2002520286A/ja
Publication of JP2002520286A5 publication Critical patent/JP2002520286A5/ja
Withdrawn legal-status Critical Current

Links

JP2000558822A 1998-07-09 1999-06-18 Gaba類縁体及びカフェインを含んでなる組成物 Withdrawn JP2002520286A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9213198P 1998-07-09 1998-07-09
US60/092,131 1998-07-09
PCT/US1999/013670 WO2000002562A1 (en) 1998-07-09 1999-06-18 Compositions comprising gaba analogs and caffeine

Publications (2)

Publication Number Publication Date
JP2002520286A JP2002520286A (ja) 2002-07-09
JP2002520286A5 true JP2002520286A5 (enExample) 2006-08-10

Family

ID=22231777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000558822A Withdrawn JP2002520286A (ja) 1998-07-09 1999-06-18 Gaba類縁体及びカフェインを含んでなる組成物

Country Status (13)

Country Link
US (1) US6326374B1 (enExample)
EP (1) EP1094817A1 (enExample)
JP (1) JP2002520286A (enExample)
KR (1) KR20010071777A (enExample)
AU (1) AU772156B2 (enExample)
BR (1) BR9911917A (enExample)
CA (1) CA2332915C (enExample)
ID (1) ID28277A (enExample)
NO (1) NO20010119D0 (enExample)
NZ (1) NZ508490A (enExample)
PL (1) PL345340A1 (enExample)
WO (1) WO2000002562A1 (enExample)
ZA (1) ZA200007168B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001876A (en) 1996-07-24 1999-12-14 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
WO2000061188A1 (en) * 1999-04-09 2000-10-19 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
ATE317280T1 (de) 2001-09-03 2006-02-15 Newron Pharm Spa Pharmazeutische zusammensetzung mit gabapentin oder deren analog und einem alpha-aminoamid und analgetische verwendung dieser zusammensetzung
RU2335342C2 (ru) * 2004-03-12 2008-10-10 Уорнер-Ламберт Компани Ллс C1-симметричные бисфосфиновые лиганды и их применение в асимметрическом синтезе прегабалина
JP2007530657A (ja) * 2004-04-01 2007-11-01 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Pキラル性ホスホランの調製および不斉合成でのその使用
EA200800909A1 (ru) 2004-06-21 2008-08-29 УОРНЕР-ЛАМБЕРТ КОМПАНИ ЭлЭлСи Получение прегабалина и родственных соединений
SI1809271T1 (sl) * 2004-09-10 2010-10-29 Newron Pharm Spa Uporaba (R)-(halobenziloksi) benzilamino propanamidov kot selektivnih modulatorjev natrijevih in/ali kalcijevih kanalov
EP1963280B1 (en) 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
CH699327B1 (de) 2007-02-14 2010-03-15 Oerlikon Heberlein Temco Wattw Vorrichtung zum gleichzeitigen Behandeln von mehreren multifilen Fäden.
JP5592790B2 (ja) 2007-08-06 2014-09-17 トリニティ ラボラトリーズ インコーポレイテッド 慢性疼痛およびニューロパシーに関連する疼痛を治療する医薬組成物
SG157299A1 (en) * 2008-05-09 2009-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
US20100190752A1 (en) 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
WO2012059797A1 (en) 2010-11-04 2012-05-10 Lupin Limited Process for synthesis of (s) - pregabalin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656177A (en) 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US5248678A (en) * 1992-06-30 1993-09-28 Fractal Laboratories, Inc. Methods for increasing arousal and alertness and for the amelioration of comatose states
CA2170485C (en) * 1993-09-07 2000-11-07 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
US5443838A (en) 1993-09-15 1995-08-22 Koenig, Jr.; Steven M. Nutritional supplementation system
PL185991B1 (pl) * 1996-03-14 2003-09-30 Warner Lambert Co Nowe podstawione cykliczne aminokwasy i kompozycja farmaceutyczna
DE69733081T2 (de) * 1996-08-23 2006-05-11 Endo Pharmaceuticals Inc. (n.d.Ges.d. Staates Delaware) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
AU733896B2 (en) * 1996-10-23 2001-05-31 Warner-Lambert Company Substituted gamma aminobutyric acids as pharmaceutical agents
WO1999012537A1 (en) * 1997-09-08 1999-03-18 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same

Similar Documents

Publication Publication Date Title
JP2002520286A5 (enExample)
JP2001515033A5 (enExample)
JP2003528918A5 (enExample)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2002508352A5 (ja) 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体)
JP2001515859A5 (enExample)
JP2002502874A5 (enExample)
JP2002519425A5 (enExample)
JP2002519434A5 (enExample)
JP2002508362A5 (ja) 1−置換−1−アミノメチル−シクロアルカン誘導体(=ガバペンチン類縁体)
JP2003531118A5 (enExample)
JP2002518502A5 (enExample)
JP2001512743A5 (enExample)
JP2002541233A5 (enExample)
JP2002509153A5 (enExample)
JP2002541198A5 (ja) 失禁治療用医薬組成物
JP2001526218A5 (enExample)
CA2526534A1 (en) Compounds and methods for delivery of prostacyclin analogs
JP2001520998A5 (enExample)
JP2003514783A5 (enExample)
JP2004530641A5 (enExample)
JP2002531505A5 (enExample)
JP2002508361A5 (enExample)
JP2005510540A5 (enExample)
JP2003503449A5 (enExample)